Tradr 2X Long Innovation ETF (NASDAQ:TARK – Get Free Report) was the target of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 172,000 shares, a growth of 42.0% from the November 15th total of 121,100 shares. Based on an average daily trading volume, of 79,800 shares, the days-to-cover ratio is currently 2.2 days.
Tradr 2X Long Innovation ETF Stock Up 1.5 %
Shares of TARK traded up $0.75 during trading hours on Friday, reaching $51.76. 31,164 shares of the company traded hands, compared to its average volume of 130,980. The stock has a fifty day simple moving average of $39.65 and a 200 day simple moving average of $33.27. Tradr 2X Long Innovation ETF has a fifty-two week low of $20.00 and a fifty-two week high of $55.61.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in Tradr 2X Long Innovation ETF stock. Western Pacific Wealth Management LP purchased a new stake in Tradr 2X Long Innovation ETF (NASDAQ:TARK – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 950 shares of the company’s stock, valued at approximately $62,000. Western Pacific Wealth Management LP owned 0.10% of Tradr 2X Long Innovation ETF at the end of the most recent reporting period.
About Tradr 2X Long Innovation ETF
The AXS 2X Innovation ETF (TARK) is an exchange-traded fund that is based on the ARK Innovation ETF index. The fund is an actively-managed fund-of-fund that seeks to achieve 2x the return, for a single day, of the ARK Innovation ETF (ARKK) through swap agreements with major global financial institutions.
Recommended Stories
- Five stocks we like better than Tradr 2X Long Innovation ETF
- What does consumer price index measure?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How to Calculate Stock Profit
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Ride Out The Recession With These Dividend KingsĀ
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Tradr 2X Long Innovation ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tradr 2X Long Innovation ETF and related companies with MarketBeat.com's FREE daily email newsletter.